Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate

INTRODUCTION: Vitamin K antagonists (VKA) and non‐vitamin K oral antagonist anticoagulants (NOAC) are used in the clinic to reduce risk of thrombosis. However, they also exhibit vascular off‐target effects. The aim of this study is to compare VKA and NOAC on atherosclerosis progression and calcifica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thromb Haemost
Autores principales: van Gorp, Rick H., Dijkgraaf, Ingrid, Bröker, Vanessa, Bauwens, Matthias, Leenders, Peter, Jennen, Danyel, Dweck, Marc R., Bucerius, Jan, Briedé, Jacco J., van Ryn, Joanne, Brandenburg, Vincent, Mottaghy, Felix, Spronk, Henri M. H., Reutelingsperger, Chris P., Schurgers, Leon J.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2021
Materias:
VASCULAR BIOLOGY
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252511/
https://ncbi.nlm.nih.gov/pubmed/33687782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15289
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares